Sport Cricket England cricket team England's selection options for the third Ashes Test with three players under threat England face some crucial selection decisions ahead of the must-win third Test ...

After Australia’s long first innings finally came to an end on 511, England faced a tricky final period with the bat under the Gabba lights. Watch The Ashes 2025/26 LIVE and ad-break free during play ...

Waymo LLC this week announced plans to bring its robotaxi service to three more cities: New Orleans, Minneapolis, and Tampa, Fla. In each of these cities, the company said it will begin laying the ...

Xiaomi has quietly begun testing HyperOS 3, based on Android 15, and a dozen devices are already running early builds. For many of them, this will also be the last major software upgrade they ever ...

The Rolex Shanghai Masters announced Tuesday that four-time champion Novak Djokovic would make his 14th main-draw appearance at the Masters 1000 event. For Djokovic, Shanghai will mark the 24-time ...

A Waymo self-driving vehicle operates in San Francisco on Wednesday, Aug. 21, 2024. The company will begin rolling out service to San Francisco International Airport, initially on specific roads and ...

Xiaomi has now officially started rolling out its HyperOS 3 beta to global markets. The first test kicked off in China a month ago. The smartphone maker is currently inviting beta testers to provide ...

Apart from the Find X9 series, Oppo is also said to be developing its next-generation Reno-branded phones – the Reno 15 series. Since the Reno 11 lineup, which debuted in November 2023, the Reno range ...

FRANKFURT — Swiss drugmaker Roche (ROG.S), said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious hospital infections into the third and ...

FRANKFURT, May 26 (Reuters) - Swiss drugmaker Roche (ROG.S), opens new tab said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that causes serious ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter, randomized, ...